$4.56 0.06 (+1.33%)
2/9/2010 4:00 PM

Acura Pharmaceuticals Inc. (ACUR)

CAPS Rating: 1 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Current Price $4.56 Mkt Cap $195.94M
Open $4.55 P/E Ratio 44.85
Prev. Close $4.50 Div. (Yield) N/A (N/A)
Daily Range $4.50 - $4.65 Volume 14,355
52-Wk Range $4.00 - $9.00 Avg. Daily Vol. 0

Related News and Articles

Caps

How do you think ACUR will perform vs the S&P 500?

Add Stock to Watchlist

All Members

41 Outperform
29 Underperform
 

All-Star Members

12 Outperform
13 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top ACUR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

davidr825 (< 20)
Submitted June 13, 2008

Unique delivery of controlled substances will make this a winner - especially when coupled with King Pharmaceutical

tcampbellla (90.80)
Submitted October 29, 2007

No thanks.

ACUR VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about ACUR.

Recs

0
Member Avatar steelersnextat7 (< 20) Submitted: 9/22/2009 2:10:56 AM : Outperform Start Price: $4.88 ACUR Score: -6.69

FDA approval is looming in Jan to March 2010 when it does acura will hit 12 to 15 or be bought or both king will scoop it up

Recs

0
Member Avatar TSIF (98.89) Submitted: 6/29/2009 10:18:16 PM : Outperform Start Price: $6.01 ACUR Score: -44.60

Acura Pharmaceuticals got bloodied (36%) when it received word from the FDA that it had a "labeling" issue for it's experimental pain drug Acurox which would delay a response past the expected June 30th date. While this could be bad news, as it adds another layer to the process and delays, it appears to me to be as expected for a drug that includes oxycodone WHILE trying to meet the new FDA guidelines that attempt to curb prescription drug abuse, which can be common with opioid pain drugs. Acura's "Aversion(r)" (abuse deterrent) Technology, has the issue of being the first to test the new guidelines and it should not be unexpected for the FDA to ensure they are establishing a clear set of guidelines. Once through these hurdles Acura will be the "poster child" for the new rules and will be able to see it's drug where other companies cannot without similar approval. Several analysts expect the dreaded "complete response" letter from the FDA which could set things back 6-18 months if more data is needed, but this delay to me appears to only be a cautious approach from the FDA, not a formal "complete response". If I'm wrong, my CAPs will need some pain reliever!

Recs

0
Member Avatar TLassen (64.56) Submitted: 3/21/2009 1:24:34 PM : Outperform Start Price: $5.66 ACUR Score: -44.91

Ticker Symbol ACUR
Name of Company ACURA PHARMACEUTICAL
Date March 1, 2009
Earnings Report (Qtr/YR) 4TH QTR 2008

Strategic Score 71%

Intrinsic Value $5.21
Buy at (Based on MOS) $3.18
Sell Profits (Based on MOS) $8.12
Premium or (discount) MOS 1%
10 year Bond (risk free) 2.80%
Premium 5.00%
Discount Rate 7.80%
Growth (Retention Model) 39.05%
Margin of Safety 39%

Leaderboard

Find the members with the highest scoring picks in ACUR.

Score Leader

BigDMan64

BigDMan64 (99.55) Score: +116.29

The Score Leader is the member with the highest score across all their picks in ACUR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
kansalainen 25.31 12/1/2008 Underperform 5Y $8.00 -43.00% +25.78% +68.78
embodiedheart 94.09 12/1/2008 Underperform 5Y $7.41 -38.46% +29.28% +67.74
mrstlouis 45.09 4/7/2009 Underperform 3M $6.35 -28.19% +31.71% +59.90
SmallCapsInvstr 83.38 4/28/2009 Underperform 1Y $6.46 -29.41% +27.50% +56.91
RenwayGlobal 79.68 6/5/2009 Underperform 5Y $7.25 -37.10% +14.29% +51.39
MoeLarryShemp 62.99 10/16/2007 Underperform 3Y $20.00 -77.20% -27.02% +50.18
odmonk 40.92 10/29/2007 11/13/2009 Underperform 1Y $19.50 -76.62% -27.02% +49.59 1 Comment
tcampbellla 90.80 10/29/2007 Underperform 5Y $19.30 -76.37% -27.13% +49.24 5 Comments
dow13000 < 20 10/3/2007 Underperform 5Y $18.40 -75.22% -26.83% +48.38
SissorsC < 20 10/26/2007 Underperform 3W $18.10 -74.81% -26.61% +48.20

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ACUR.

Featured Broker Partners